TOLERABILITY
Clinical trials for TOLERABILITY explained in plain language.
Never miss a new study
Get alerted when new TOLERABILITY trials appear
Sign up with your email to follow new studies for TOLERABILITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New vaginal capsule aims to tackle stubborn bacterial vaginosis
Disease control Not yet recruitingThis study tests a new drug called GenSci142, given as a vaginal capsule, for treating bacterial vaginosis (BV). About 30 women with BV will receive either GenSci142 or a standard antibiotic cream to compare safety and how well each works. The goal is to see if the new capsule is…
Matched conditions: TOLERABILITY
Phase: PHASE1 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New pill YR011 enters first human safety trial
Knowledge-focused Not yet recruitingThis Phase 1 trial tests the safety and tolerability of a new oral drug called YR011 in 64 healthy volunteers. The drug blocks a potassium channel involved in immune cell activity. Participants receive either YR011 or a placebo in single or multiple doses. The study aims to find …
Matched conditions: TOLERABILITY
Phase: PHASE1 • Sponsor: Hangzhou Yirui Pharmaceutical Technology Co., Ltd • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC